Gustaaf van Imhoff

Search results

• 2016

  Disturbed antigen presentation in classical Hodgkin Lymphoma; implications for immune checkpoint inhibitor therapy

  Nijland, M., Visser, L., Veenstra, R., Kushekhar, K., van Imhoff, G., Berg, van den, A. & Diepstra, A., 20-Oct-2016, In: Haematologica. 101, 1 p., T009.

  Research output: Contribution to journal › Meeting Abstract › Academic

  Open Access

  File

  • Classical Hodgkin Lymphoma 100%
  • Human Leukocyte Antigen 100%
  • Antigen Presentation 100%
  • Immune Checkpoint Inhibitor 100%
  • Immune Checkpoint Inhibitor Therapy 100%
  1429 Downloads (Pure)

• Mid-treatment TARC and mid-treatment FGD-PET predict for progression free survival in classical hodgkin lymphom

  Plattel, W. J., Berg, van den, A., Visser, L., Glaudemans, A., Diepstra, A. & van Imhoff, G., 20-Oct-2016, In: Haematologica. 101, p. 31-31 1 p., T014.

  Research output: Contribution to journal › Meeting Abstract › Academic

  Open Access

  File
  438 Downloads (Pure)
• 2015

  Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma

  Nijland, M., Boslooper, K., Van den Berg, A., Kluin-Nelemans, H. C., Joosten, P., Storm, H., Kibbelaar, R., van Imhoff, G. & Hoogendoorn, M., 3-Dec-2015, In: Blood. 126, 23, 3 p.

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2010

  EXPRESSION OF THE C-MET ONCOGENE CORRELATES WITH FAVORABLE PROGRESSION FREE SURVIVAL IN CLASSICAL HODGKIN LYMPHOMA

  Xu, C., van den Berg, A., Plattel, W., Ruether, N., Huang, X., Wang, M., de Jong, D., Vos, H., van Imhoff, G., Viardot, A., Moeller, P., Poppema, S., Diepstra, A. & Visser, L., 31-Oct-2010, In: Haematologica. 95, p. S4-S4 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

• PROSPECTIVE ANALYSIS OF PLASMA LEVELS OF THYMUS AND ACTIVATION REGULATED CHEMOKINE (TARC) IN PRIMARY AND RELAPSED CLASSICAL HODGKIN LYMPHOMA PATIENTS

  Plattel, W., van den Berg, A., Van der Graaf, A. M., Poppema, S., Visser, L., Diepstra, A. & Van Imhoff, G. W., 31-Oct-2010, In: Haematologica. 95, p. S5-S5 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2007

  Treatment of MALT lymphoma in Sjogren's syndrome: a retrospective clinical study and a proposal for treatment guidelines

  Pijpe, J., Bootsma, H., Vissink, A., Spijkervet, F. K. L., Roodenburg, J. L. N., Kluin, P. M., Kallenberg, C. G. M. & van Imhoff, G. W., May-2007, In: Oral Oncology. p. 214-214 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2006

  (Re)Treatment with rituximab inpatients with active primary Sjogren's Syndrome

  Meijer, J. M., Pijpe, J., Van Imhoff, G. W., Vissink, A., Spijkervel, F. K. L., Mansour, K., Kallenberg, C. G. M. & Bootsma, H., Jul-2006, In: Annals of the Rheumatic Diseases. 65, p. 476-476 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

• Primary Sjogren's syndrome: Retreatment with rituximab and long-term follow-up.

  Meijer, J. M., Pijpe, J., van Imhoff, G. W., Vissink, A., Spijkervet, F. K. L., Mansour, K., Kallenberg, C. G. M. & Bootsma, H., Sept-2006, In: ARTHRITIS AND RHEUMATISM. 54, 9, p. S255-S255 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

  1 Citation (Scopus)

• Treatment of MALT lymphoma in Sjogren's syndrome: A retrospective clinical study and a proposal for treatment guidelines.

  Pijpe, J., Bootsma, H., Vissink, A., Spijkervet, F. K. L., Roodenburg, J. L. N., Kluim, P. M., Kallenberg, C. G. M. & van Imhoff, G. W., Sept-2006, In: ARTHRITIS AND RHEUMATISM. 54, 9, p. S255-S255 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2005

  Rituximab in the treatment of primary Sjogren's syndrome: A phase II study

  Pijpe, J., Van Imhoff, G., Vissink, A., Kallenberg, C. & Bootsma, H., Jul-2005, In: Annals of the Rheumatic Diseases. 64, p. 56-56 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

  11 Citations (Scopus)
• 2004

  Decrease of activity in Sjogren's syndrome after treatment with rituximab for associated malt-lymphoma

  Pijpe, J., Van Imhoff, G., Kluin, P., Spijkervet, F., Roodenburg, J., Vissink, A., Kallenberg, C. & Bootsma, H., Jul-2004, In: Annals of the Rheumatic Diseases. 63, p. 354-354 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

  101 Citations (Scopus)

• Rituximab (anti-CD20) for the treatment of primary Sjogren's syndrome.

  Pijpe, J., Bootsma, H., Van Imhoff, G., Vissink, A., Mansour, K., Van der Wal, J., Roozendaal, C., Kluin, P., Spijkervet, F., Roodenburg, J. & Kallenberg, C., Sept-2004, In: ARTHRITIS AND RHEUMATISM. 50, 9, p. S575-S575 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic